Population
In vitro and in vivo models of insulin resistance (including the fructose-fed hamster model) and human studies
Design
Review
Authors
Loading...
Extends mechanistic insights into metabolic dyslipidemia; leaves open whether targeting oversecretion alters outcomes in insulin resistance.
This review highlights that metabolic dyslipidemia in insulin resistance is driven by a complex interaction of enhanced free fatty acid flux, hyperinsulinemia, and attenuated insulin signaling leading to hepatic and intestinal lipoprotein overproduction.
Khosrow Adeli (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: